Skip to content
Screener

GeneDx Holdings WGS Pre-Tax Income

Discontinued — last reported Q1 '26

Pre-Tax Income at other companies

Natera, Inc. logo
Natera, Inc.NTRA
-$67.23M+33.2%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
-$25.98M-122%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$8.82M+122%
Personalis, Inc. logo
Personalis, Inc.PSNL
-$30.02M-90.7%
NeoGenomics logo
NeoGenomicsNEO
$1.83M+104%
Quest Diagnostics logo
Quest DiagnosticsDGX
$412M+7.3%

Other financials

Income statement

See full
Revenue$102.3M+17.4%
Gross profit$68.2M+16.6%
Operating income-$57.5M-1,163%
Net income-$63.3M-870%
EPS (diluted)-$2.16-839%

Balance sheet

See full
Cash & equivalents$94.9M-5.7%
Total debt$96.7M+82.5%
Total equity$254.1M-1.3%
Total assets$506.3M+13.4%

Cash flow

See full
Operating cash flow-$32.4M-418%
CapEx$6.5M+5.3%
Free cash flow-$38.9M-1,059%

Valuation

See full
Market cap$2.32B-26.9%
Enterprise value$2.32B-26.3%
P/S5.3×-3.5×

Profitability

See full
Gross margin69.6%+4.3pp
Operating margin-14.9%
Net margin-17.6%
FCF margin3.8%+2.1pp

Returns & leverage

See full
Return on equity-30.4%
Debt / equity0.4×+0.2×
Current ratio3.1×-0.2×

Where this comes from

Reported directly by GeneDx Holdings in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The source filing: GeneDx Holdings’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001818331-26-000041
Line itemThree months ended March 31, 20262025
Loss on extinguishment of debt(6,565)
Other (expense) income, net(206)209
Total non-operating expense, net(4,948)(1,531)
Loss before income taxes(62,419)(6,082)
Income tax expense(897)(447)
Net loss$(63,316)$(6,529)
Other comprehensive (loss) income, net of tax
Unrealized (loss) gain related to available for sale securities, net(253)75

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is GeneDx Holdings's pre-tax income?
GeneDx Holdings (WGS) reported pre-tax income of -$62.42M in Q1 2026.
How has GeneDx Holdings's pre-tax income changed year-over-year?
GeneDx Holdings's pre-tax income decreased by 926.3% year-over-year, from -$6.08M to -$62.42M.
What is the long-term trend for GeneDx Holdings's pre-tax income?
Over 3 years (2021 to 2025), GeneDx Holdings's pre-tax income has grown at a -55.8% compound annual growth rate (CAGR), from -$245.39M to -$21.14M.
What does pre-tax income mean?
Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.

Ask your AI about GeneDx Holdings's pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude